Skip to main content
. Author manuscript; available in PMC: 2017 Jul 10.
Published in final edited form as: Exp Neurol. 2013 May 24;248:53–61. doi: 10.1016/j.expneurol.2013.05.011

Fig. 10.

Fig. 10

Replication of 7 dpi deferasirox treatment or 14 dpi treatment fails to reproduce functional improvements after SCI. Animals were given deferasirox at 160 mg/kg/day for either 7 or 14 days post-injury and locomotor function was tested using the BBB scale. Neither treatment paradigm altered recovery of hindlimb function.